IBDEI041 ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9667,0)
 ;;=C77.1^^48^488^130
 ;;^UTILITY(U,$J,358.3,9667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9667,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,9667,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,9667,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,9668,0)
 ;;=C77.0^^48^488^146
 ;;^UTILITY(U,$J,358.3,9668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9668,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,9668,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,9668,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,9669,0)
 ;;=C77.8^^48^488^147
 ;;^UTILITY(U,$J,358.3,9669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9669,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,9669,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,9669,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,9670,0)
 ;;=C79.51^^48^488^117
 ;;^UTILITY(U,$J,358.3,9670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9670,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,9670,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,9670,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,9671,0)
 ;;=C79.52^^48^488^116
 ;;^UTILITY(U,$J,358.3,9671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9671,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,9671,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,9671,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,9672,0)
 ;;=C79.31^^48^488^118
 ;;^UTILITY(U,$J,358.3,9672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9672,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,9672,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,9672,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,9673,0)
 ;;=C79.72^^48^488^133
 ;;^UTILITY(U,$J,358.3,9673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9673,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,9673,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,9673,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,9674,0)
 ;;=C78.02^^48^488^137
 ;;^UTILITY(U,$J,358.3,9674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9674,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,9674,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,9674,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,9675,0)
 ;;=C78.7^^48^488^142
 ;;^UTILITY(U,$J,358.3,9675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9675,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,9675,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,9675,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,9676,0)
 ;;=C79.71^^48^488^155
 ;;^UTILITY(U,$J,358.3,9676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9676,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,9676,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,9676,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,9677,0)
 ;;=C78.01^^48^488^159
 ;;^UTILITY(U,$J,358.3,9677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9677,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,9677,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,9677,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,9678,0)
 ;;=C79.70^^48^488^110
 ;;^UTILITY(U,$J,358.3,9678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9678,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,9678,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,9678,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,9679,0)
 ;;=C78.00^^48^488^143
 ;;^UTILITY(U,$J,358.3,9679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9679,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,9679,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,9679,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,9680,0)
 ;;=D57.1^^48^488^187
 ;;^UTILITY(U,$J,358.3,9680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9680,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,9680,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,9680,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,9681,0)
 ;;=D75.1^^48^488^185
 ;;^UTILITY(U,$J,358.3,9681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9681,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,9681,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,9681,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,9682,0)
 ;;=C90.30^^48^488^188
 ;;^UTILITY(U,$J,358.3,9682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9682,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,9682,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,9682,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,9683,0)
 ;;=D56.3^^48^488^189
 ;;^UTILITY(U,$J,358.3,9683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9683,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,9683,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,9683,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,9684,0)
 ;;=D56.9^^48^488^190
 ;;^UTILITY(U,$J,358.3,9684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9684,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,9684,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,9684,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,9685,0)
 ;;=M31.1^^48^488^192
 ;;^UTILITY(U,$J,358.3,9685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9685,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,9685,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,9685,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,9686,0)
 ;;=D51.2^^48^488^193
 ;;^UTILITY(U,$J,358.3,9686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9686,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,9686,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,9686,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,9687,0)
 ;;=D05.92^^48^488^36
 ;;^UTILITY(U,$J,358.3,9687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9687,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,9687,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,9687,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,9688,0)
 ;;=D05.91^^48^488^38
 ;;^UTILITY(U,$J,358.3,9688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9688,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,9688,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,9688,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,9689,0)
 ;;=D05.90^^48^488^34
 ;;^UTILITY(U,$J,358.3,9689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9689,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,9689,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,9689,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,9690,0)
 ;;=D51.0^^48^488^194
 ;;^UTILITY(U,$J,358.3,9690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9690,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,9690,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,9690,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,9691,0)
 ;;=D51.1^^48^488^195
 ;;^UTILITY(U,$J,358.3,9691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9691,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,9691,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,9691,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,9692,0)
 ;;=D51.9^^48^488^197
 ;;^UTILITY(U,$J,358.3,9692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9692,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,9692,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,9692,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,9693,0)
 ;;=D68.0^^48^488^199
 ;;^UTILITY(U,$J,358.3,9693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9693,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,9693,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,9693,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,9694,0)
 ;;=C88.0^^48^488^200
 ;;^UTILITY(U,$J,358.3,9694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9694,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,9694,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,9694,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,9695,0)
 ;;=C91.02^^48^488^3
 ;;^UTILITY(U,$J,358.3,9695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9695,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,9695,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,9695,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,9696,0)
 ;;=C92.02^^48^488^6
 ;;^UTILITY(U,$J,358.3,9696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9696,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,9696,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,9696,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,9697,0)
 ;;=D09.3^^48^488^46
 ;;^UTILITY(U,$J,358.3,9697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9697,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,9697,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,9697,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,9698,0)
 ;;=C22.0^^48^488^87
 ;;^UTILITY(U,$J,358.3,9698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9698,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,9698,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,9698,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,9699,0)
 ;;=C24.9^^48^488^114
 ;;^UTILITY(U,$J,358.3,9699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9699,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,9699,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,9699,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,9700,0)
 ;;=C50.922^^48^488^138
 ;;^UTILITY(U,$J,358.3,9700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9700,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,9700,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,9700,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,9701,0)
 ;;=C34.91^^48^488^156
 ;;^UTILITY(U,$J,358.3,9701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9701,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,9701,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,9701,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,9702,0)
 ;;=C50.921^^48^488^160
 ;;^UTILITY(U,$J,358.3,9702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9702,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,9702,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,9702,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,9703,0)
 ;;=C90.02^^48^488^172
 ;;^UTILITY(U,$J,358.3,9703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9703,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,9703,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,9703,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,9704,0)
 ;;=D51.9^^48^488^25
 ;;^UTILITY(U,$J,358.3,9704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9704,1,3,0)
 ;;=3^Anemia in Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,9704,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,9704,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,9705,0)
 ;;=C79.51^^48^488^31
 ;;^UTILITY(U,$J,358.3,9705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9705,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,9705,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,9705,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,9706,0)
 ;;=C80.1^^48^488^167
 ;;^UTILITY(U,$J,358.3,9706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9706,1,3,0)
 ;;=3^Malig Neop,Primary,Unspec Site
 ;;^UTILITY(U,$J,358.3,9706,1,4,0)
 ;;=4^C80.1
 ;;^UTILITY(U,$J,358.3,9706,2)
 ;;=^5001389
 ;;^UTILITY(U,$J,358.3,9707,0)
 ;;=C80.0^^48^488^168
 ;;^UTILITY(U,$J,358.3,9707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9707,1,3,0)
 ;;=3^Malig Neop,Unspec Primary or Secondary
 ;;^UTILITY(U,$J,358.3,9707,1,4,0)
 ;;=4^C80.0
 ;;^UTILITY(U,$J,358.3,9707,2)
 ;;=^5001388
 ;;^UTILITY(U,$J,358.3,9708,0)
 ;;=E28.39^^48^488^92
 ;;^UTILITY(U,$J,358.3,9708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9708,1,3,0)
 ;;=3^Hypogonadism,Ovarian
 ;;^UTILITY(U,$J,358.3,9708,1,4,0)
 ;;=4^E28.39
 ;;^UTILITY(U,$J,358.3,9708,2)
 ;;=^5002752
 ;;^UTILITY(U,$J,358.3,9709,0)
 ;;=E29.1^^48^488^93
 ;;^UTILITY(U,$J,358.3,9709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9709,1,3,0)
 ;;=3^Hypogonadism,Testicular
 ;;^UTILITY(U,$J,358.3,9709,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,9709,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,9710,0)
 ;;=C96.20^^48^488^107
 ;;^UTILITY(U,$J,358.3,9710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9710,1,3,0)
 ;;=3^Malig Mast Cell Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,9710,1,4,0)
 ;;=4^C96.20
 ;;^UTILITY(U,$J,358.3,9710,2)
 ;;=^5151293
 ;;^UTILITY(U,$J,358.3,9711,0)
 ;;=C96.22^^48^488^169
 ;;^UTILITY(U,$J,358.3,9711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9711,1,3,0)
 ;;=3^Mast Cell Sarcoma
 ;;^UTILITY(U,$J,358.3,9711,1,4,0)
 ;;=4^C96.22
 ;;^UTILITY(U,$J,358.3,9711,2)
 ;;=^5151295
 ;;^UTILITY(U,$J,358.3,9712,0)
 ;;=D64.9^^48^488^26
 ;;^UTILITY(U,$J,358.3,9712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9712,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,9712,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,9712,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,9713,0)
 ;;=Z85.818^^48^489^86
 ;;^UTILITY(U,$J,358.3,9713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9713,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
 ;;^UTILITY(U,$J,358.3,9713,1,4,0)
 ;;=4^Z85.818
 ;;^UTILITY(U,$J,358.3,9713,2)
 ;;=^5063439
 ;;^UTILITY(U,$J,358.3,9714,0)
 ;;=Z85.819^^48^489^87
 ;;^UTILITY(U,$J,358.3,9714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9714,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx,Unspec
 ;;^UTILITY(U,$J,358.3,9714,1,4,0)
 ;;=4^Z85.819
 ;;^UTILITY(U,$J,358.3,9714,2)
 ;;=^5063440
 ;;^UTILITY(U,$J,358.3,9715,0)
 ;;=Z85.01^^48^489^82
 ;;^UTILITY(U,$J,358.3,9715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9715,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Esophagus
 ;;^UTILITY(U,$J,358.3,9715,1,4,0)
 ;;=4^Z85.01
 ;;^UTILITY(U,$J,358.3,9715,2)
 ;;=^5063395
 ;;^UTILITY(U,$J,358.3,9716,0)
 ;;=Z85.028^^48^489^93
 ;;^UTILITY(U,$J,358.3,9716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9716,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Stomach
 ;;^UTILITY(U,$J,358.3,9716,1,4,0)
 ;;=4^Z85.028
 ;;^UTILITY(U,$J,358.3,9716,2)
 ;;=^5063397
 ;;^UTILITY(U,$J,358.3,9717,0)
 ;;=Z85.038^^48^489^84
 ;;^UTILITY(U,$J,358.3,9717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9717,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Large Intestine
 ;;^UTILITY(U,$J,358.3,9717,1,4,0)
 ;;=4^Z85.038
 ;;^UTILITY(U,$J,358.3,9717,2)
 ;;=^5063399
 ;;^UTILITY(U,$J,358.3,9718,0)
 ;;=Z85.048^^48^489^91
 ;;^UTILITY(U,$J,358.3,9718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9718,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Rectum,Rectosig Junct & Anus
 ;;^UTILITY(U,$J,358.3,9718,1,4,0)
 ;;=4^Z85.048
 ;;^UTILITY(U,$J,358.3,9718,2)
 ;;=^5063401
 ;;^UTILITY(U,$J,358.3,9719,0)
 ;;=Z85.118^^48^489^80
 ;;^UTILITY(U,$J,358.3,9719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9719,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Bronchus & Lung
 ;;^UTILITY(U,$J,358.3,9719,1,4,0)
 ;;=4^Z85.118
 ;;^UTILITY(U,$J,358.3,9719,2)
 ;;=^5063408
 ;;^UTILITY(U,$J,358.3,9720,0)
 ;;=Z85.21^^48^489^85
 ;;^UTILITY(U,$J,358.3,9720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9720,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Larynx
 ;;^UTILITY(U,$J,358.3,9720,1,4,0)
 ;;=4^Z85.21
 ;;^UTILITY(U,$J,358.3,9720,2)
 ;;=^5063411
 ;;^UTILITY(U,$J,358.3,9721,0)
 ;;=Z85.3^^48^489^79
 ;;^UTILITY(U,$J,358.3,9721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9721,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,9721,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,9721,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,9722,0)
 ;;=Z85.41^^48^489^81
 ;;^UTILITY(U,$J,358.3,9722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9722,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,9722,1,4,0)
 ;;=4^Z85.41
 ;;^UTILITY(U,$J,358.3,9722,2)
 ;;=^5063418
 ;;^UTILITY(U,$J,358.3,9723,0)
 ;;=Z85.43^^48^489^89
 ;;^UTILITY(U,$J,358.3,9723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9723,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Ovary
 ;;^UTILITY(U,$J,358.3,9723,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,9723,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,9724,0)
 ;;=Z85.46^^48^489^90
 ;;^UTILITY(U,$J,358.3,9724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9724,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,9724,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,9724,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,9725,0)
 ;;=Z85.47^^48^489^94
 ;;^UTILITY(U,$J,358.3,9725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9725,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,9725,1,4,0)
 ;;=4^Z85.47
 ;;^UTILITY(U,$J,358.3,9725,2)
 ;;=^5063424
 ;;^UTILITY(U,$J,358.3,9726,0)
 ;;=Z85.51^^48^489^78
 ;;^UTILITY(U,$J,358.3,9726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9726,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Bladder
 ;;^UTILITY(U,$J,358.3,9726,1,4,0)
 ;;=4^Z85.51
 ;;^UTILITY(U,$J,358.3,9726,2)
 ;;=^5063428
 ;;^UTILITY(U,$J,358.3,9727,0)
 ;;=Z85.528^^48^489^83
 ;;^UTILITY(U,$J,358.3,9727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9727,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,9727,1,4,0)
 ;;=4^Z85.528
 ;;^UTILITY(U,$J,358.3,9727,2)
 ;;=^5063430
 ;;^UTILITY(U,$J,358.3,9728,0)
 ;;=Z85.6^^48^489^74
 ;;^UTILITY(U,$J,358.3,9728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9728,1,3,0)
 ;;=3^Personal Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,9728,1,4,0)
 ;;=4^Z85.6
 ;;^UTILITY(U,$J,358.3,9728,2)
 ;;=^5063434
 ;;^UTILITY(U,$J,358.3,9729,0)
 ;;=Z85.72^^48^489^98
 ;;^UTILITY(U,$J,358.3,9729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9729,1,3,0)
 ;;=3^Personal Hx of Non-Hodgkin Lymphomas
 ;;^UTILITY(U,$J,358.3,9729,1,4,0)
 ;;=4^Z85.72
 ;;^UTILITY(U,$J,358.3,9729,2)
 ;;=^5063436
 ;;^UTILITY(U,$J,358.3,9730,0)
 ;;=Z85.79^^48^489^88
 ;;^UTILITY(U,$J,358.3,9730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9730,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
 ;;^UTILITY(U,$J,358.3,9730,1,4,0)
 ;;=4^Z85.79
 ;;^UTILITY(U,$J,358.3,9730,2)
 ;;=^5063437
 ;;^UTILITY(U,$J,358.3,9731,0)
 ;;=Z85.820^^48^489^77
 ;;^UTILITY(U,$J,358.3,9731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9731,1,3,0)
 ;;=3^Personal Hx of Malig Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,9731,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,9731,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,9732,0)
 ;;=Z85.828^^48^489^92
 ;;^UTILITY(U,$J,358.3,9732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9732,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Skin
 ;;^UTILITY(U,$J,358.3,9732,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,9732,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,9733,0)
 ;;=Z85.71^^48^489^72
 ;;^UTILITY(U,$J,358.3,9733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9733,1,3,0)
 ;;=3^Personal Hx of Hodgkin Lymphoma
 ;;^UTILITY(U,$J,358.3,9733,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,9733,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,9734,0)
 ;;=Z65.8^^48^489^144
 ;;^UTILITY(U,$J,358.3,9734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9734,1,3,0)
 ;;=3^Psychosocial Circumstance Related Problems
 ;;^UTILITY(U,$J,358.3,9734,1,4,0)
 ;;=4^Z65.8
 ;;^UTILITY(U,$J,358.3,9734,2)
 ;;=^5063185
 ;;^UTILITY(U,$J,358.3,9735,0)
 ;;=Z86.11^^48^489^109
 ;;^UTILITY(U,$J,358.3,9735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9735,1,3,0)
 ;;=3^Personal Hx of Tuberculosis
